An Indirect Treatment Comparison of the Cardiovascular Protective Effect of Semaglutide vs. Liraglutide in Subjects with Type 2 Diabetes2023-06-200 PRE AI BBarrie Chubb MMartin Bøg DOI:10.2337/db23-790-POriginalOriginal request for helpShareSaveAbstract En